Ipamorelin 5mg

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue originally developed by Novo Nordisk (research code NNC 26-0161). It acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), which is the same receptor targeted by ghrelin, the endogenous hunger hormone.

The peptide sequence (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) includes several modified amino acids that contribute to its selectivity and stability. Research has characterized Ipamorelin as one of the most selective GHS-R1a agonists available, with minimal effects on cortisol, prolactin, and other hormones in preclinical studies.

The peptide has been studied in various research contexts examining the GH/IGF-1 axis, including investigations into pulsatile versus continuous GH release patterns. Research has also explored its potential interactions with GHRH analogues in combined administration protocols.

Purity: ≥99% (HPLC)
Form: Lyophilised powder

For research use only. Not for human consumption.